In addition, we calculated IGAS events for ER+ vs. ER− subgroups, PR+ vs. PR− subgroups, HER2+ vs. HER2− subgroups, and triple-negative breast cancer (TNBC) vs. non-TNBC subgroups, respectively (Figure S1A). The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.